Journal of Clinical Medicine · 2021 · 11 citations · 14 references
MedicineRadiologySurgeryInterventional CardiologyInterventional RadiologyVascular SurgeryAcute Respiratory Distress SyndromeInterventional Radiology For HemorrhageAnticoagulation RegimenComplication Rate AnalysisCovid-19-associated Acute Respiratory Distress SyndromeInfection Risk FactorsInterventional EmbolizationSars-cov-2 InfectionSystemic AnticoagulationTreatment Of Coronavirus Infections
BACKGROUND: This study was conducted to evaluate the technical and clinical success of trans-arterial embolization (TAE) as a treatment of gastrointestinal bleeding (GIB) in Coronavirus Disease 2019 (COVID-19) patients and to describe its safety; moreover, we describe the characteristics of these patients. METHODS: Thirty-four COVID-19 hospitalized patients presented with GIB. Risk factors, drugs administered for COVID-19 infection, and clinical and biological parameters were evaluated. Furthermore, intraprocedural data and outcomes of embolization were analyzed. RESULTS: GIB was more frequent in male. Overweight, hypertension, diabetes, previous cardiac disease, and anticoagulation preadmission (48.5%) were frequently found in our population. Previous or actual COVID Acute respiratory distress syndrome (ARDS) and a high level of D-dimer were encountered in most cases. Upper GIB was more frequent than lower GIB. Technical and clinical success rates of embolization were 88.2% and 94.1%, respectively. The complication rate was 5.9%. CONCLUSIONS: Our study highlights the most frequent characteristics of COVID-19 patients with GIB. Embolization is feasible, effective, and safe.
14
Lei Pan, Mi Mu, Pengcheng Yang et al. · The American Journal of Gastroenterology · 2020 · 1.9K citations · Full text
Omid Khalilzadeh, Mark O. Baerlocher, Paul B. Shyn et al. · Journal of Vascular and Interventional Radiology · 2017 · 696 citations · Full text